-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-6-attach-2.pdf
February 02, 2017 - Recommendation to include evaluation of sleep disorders (Neurology and Sleep
Medicine, P.C.
-
www.healthcare411.ahrq.gov/ncepcr/research/disseminating-evidence/index.html
November 01, 2022 - About the National Center
Research Initiatives
Behavioral Health and Substance Use Disorders
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/strategies-to-better-manage-lipids.pptx
November 01, 2016 - current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders
-
www.healthcare411.ahrq.gov/news/newsroom/case-studies/index.html
February 01, 2024 - Training Enables Primary Care Providers in Rural New Mexico to Prescribe Medication for Opioid Use Disorders … Primary Care Providers in Pennsylvania Use Medication for Successful Treatment of Opioid Use Disorders
-
www.healthcare411.ahrq.gov/evidencenow/projects/alcohol/index.html
November 01, 2023 - Skip to main content
An official website of the Department of Health and Human Services
Careers
Contact Us
Español
FAQs
Search all AHRQ sites
Search small
Search
Menu
…
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/topics/impact-opioid-final.pdf
November 01, 2018 - Opioids AHRQ Works: Building Bridges Between Research and Practice
Opioids
Deaths from drug overdoses have risen steadily over the
past 2 decades. The misuse of opioids, such as
prescription pain medications and heroin, has become
widespread across the United States. In response to
dramatic increa…
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-2-attachment-6.pdf
January 17, 2017 - Measure 1, Section 2, Attachment 6
SNAC Submission Form Measure 1: Accurate ADHD Diagnosis
Section 2: Detailed Measure Specifications
Attachment 6: Claims Data Specification Example
DRAFT Measure #1: Accurate Diagnosis of ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
A. DESCRIPTION
Percentage of …
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-vi-a.pdf
March 01, 2011 - 296.06, 296.10-296.16, 296.22, 296.24,
296.32-296.34, 296.4*, 296.5*, 296.6*, 296.7*,
296.8*
Mood Disorders … 296.00-296.06, 296.10-296.16, 296.22, 296.24,
296.32-296.34, 296.4*, 296.5*, 296.6*, 296.7*,
Mood Disorders … 296.06, 296.10-296.16, 296.22, 296.24,
296.32-296.34, 296.4*, 296.5*, 296.6*, 296.7*,
296.8*
Mood Disorders
-
www.healthcare411.ahrq.gov/cpi/about/organization/nac/hughes.html
July 01, 2023 - graduate of Auburn University and the University of Alabama, where she earned a degree in communicative disorders
-
www.healthcare411.ahrq.gov/ncepcr/research/care-coordination/pcmh/index.html
August 01, 2022 - Excellence in Primary Care Research
Research Initiatives
Behavioral Health and Substance Use Disorders
-
www.healthcare411.ahrq.gov/ncepcr/research/health-it/index.html
September 01, 2022 - About the National Center
Research Initiatives
Behavioral Health and Substance Use Disorders
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/hmv-protocol-appendixa.pdf
October 11, 2017 - Neuron Disease/ 7062
24 *Muscular Atrophy, Spinal/ 5210
25 *Muscular Diseases/ 21214
26 *Muscular Disorders … Atrophic/ 5388
27 *Myopathies, Structural, Congenital/ 5491
28 *Myositis/ 10762
29 *Myotonic Disorders
-
www.healthcare411.ahrq.gov/data/visualizations/prevalence-fh-mfd.html
October 01, 2023 - Screening for Lipid Disorders in Children and Adolescents: An Evidence Update for the U.S.
-
www.healthcare411.ahrq.gov/cahps/surveys-guidance/hcbs/index.html
November 01, 2023 - disabilities, people with acquired brain injury, and people with severe mental illness and substance use disorders
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-16-p001-2-ef.pdf
April 01, 2016 - Academy of Pediatrics (AAP) policy statement, Identifying Infants and Young Children with
Developmental Disorders … Identifying infants and young children with developmental disorders in the medical home: an
algorithm
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_16-p001-1-ef.pdf
April 01, 2016 - Academy of Pediatrics (AAP) policy statement, Identifying Infants and Young Children with
Developmental Disorders … Identifying infants and young children with developmental disorders in the medical home: an
algorithm
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-145-fullreport.pdf
July 01, 2016 - through EPSDT, including
screening for potential developmental, mental, behavioral, and/or substance use disorders … A prospective 4-year follow-up study of attention-
deficit hyperactivity and related disorders. … with initial ADHD met the revised third edition of the Diagnostic and Statistical Manual of
Mental Disorders … A prospective 4-year follow-up study of attention-
deficit hyperactivity and related disorders. … Answer: Yes, except for those in the exclusion categories, which include: Mood Disorders
(296.xx), Autism
-
www.healthcare411.ahrq.gov/opioids/data/online-resources/opioids-elderly-nonelderly.html
February 01, 2024 - Contact Us
Español
FAQs
Home
Opioids and Substance Use Disorders
-
www.healthcare411.ahrq.gov/pqmp/publications/search.html
January 01, 2021 - Preventative screening
(1)
Quality improvement
(1)
Quality of care
(1)
Sepsis
(1)
Sickle cell disorders … Keywords: Sickle cell disorders
Use of EHR-Based Pediatric Quality Measures: Views of Health System
-
www.healthcare411.ahrq.gov/pqmp/publications/search.html?page=0
January 01, 2021 - Preventative screening
(1)
Quality improvement
(1)
Quality of care
(1)
Sepsis
(1)
Sickle cell disorders … Keywords: Sickle cell disorders
Use of EHR-Based Pediatric Quality Measures: Views of Health System